SLXN

SILEXION THERAPEUTICS CORP

SLXN·G1281K130·US·Common Stock·Healthcare - Biotechnology-Activist

SLXN (SILEXION THERAPEUTICS CORP) is held by 3 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($26,785), UBS Group AG ($662), JONES FINANCIAL COMPANIES LLLP ($32). Net institutional sentiment: Mixed.

3
Holders
Avg rating
$27,479
Total Value
50% (3)
Fund Consensus
1 buying - 1 selling
SLXNSmart Money Verdict
View all
Held by 3 funds
Who's Trading
ActivistMSMoringa Sponsor, LP10.6%Jun 23, 2026
ActivistMSMoringa Sponsor, LP33.0%May 29, 2026
InsiderSMShirvan MitchellSell $31KMar 26, 2026
ActivistMPMitchell P. Kopin9.4%Feb 13, 2026
ActivistLGLind Global Fund III LP6.4%Nov 14, 2025
ActivistMSMoringa Sponsor, LP14.6%Sep 23, 2025
ActivistLALincoln Alternative Strategies LLC6.2%Sep 15, 2025
ActivistOAOrca Capital AG4.9%Sep 15, 2025
ActivistWIWildcat Capital Management, LLC1.3%Jun 26, 2025
ActivistTHE GOLDMAN SACHS GROUP, INC.THE GOLDMAN SACHS GROUP, INC.2.4%May 13, 2025

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used